Key result
A previously healthy 30-year-old woman with COVID-19 developed acute pericarditis, pericardial effusion, and cardiac tamponade requiring an emergent subxiphoid pericardial window.
Why the study?
Few case reports have documented pericardial effusion, acute pericarditis, and cardiac tamponade in patients with COVID-19, making it important to share novel presentations of the disease.
Case Report (n=1)
No
COVID-19 can present with acute pericarditis, pericardial effusion, and cardiac tamponade, highlighting the need for broad differential diagnoses and early ultrasound evaluation in these patients.
May alert clinicians to tamponade in young COVID-19 patients; extends cardiac manifestations but leaves open causality and incidence.
BACKGROUND: This case report demonstrates pericardial effusion, acute pericarditis, and cardiac tamponade in an otherwise healthy woman who had a positive test result for coronavirus disease 2019. Few case reports have been documented on patients with this presentation, and it is important to share novel presentations of the disease as they are discovered. CASE PRESENTATION: A Caucasian patient with coronavirus disease 2019 returned to the emergency department of our hospital 2 days after her initial visit with worsening chest pain and shortness of breath. Imaging revealed new pericardial effusion since the previous visit. The patient became hypotensive, was taken for pericardial window for cardiac tamponade with a drain placed, and was treated for acute pericarditis. CONCLUSION: Much is still unknown about the implications of coronavirus disease 2019. With the novel coronavirus disease 2019 pandemic, research is still in process, and we are slowly learning about new signs and symptoms of the disease. This case report documents a lesser-known presentation of a patient with coronavirus disease 2019 and will help to further understanding of a rare presentation.
No takes yet. Share an insight, caveat, or question.
Walker et al. (2020) conducted a case report in COVID-19 with pericardial effusion and cardiac tamponade (n=1). COVID-19 was evaluated on Development of pericardial effusion and cardiac tamponade. A previously healthy 30-year-old woman with COVID-19 developed acute pericarditis, pericardial effusion, and cardiac tamponade requiring an emergent subxiphoid pericardial window.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: